Prot #010-06: A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date1/27/141/31/22

Funding

  • Merck Sharp & Dohme Corporation (Prot #010-06)